The Pharmaceutical Printed Literature Association (PPLA) and bipartisan lawmakers are urging the FDA to revise its proposed rule on patient medication information. They argue that the current digital format may hinder patient access, particularly for the elderly and rural communities. They emphasize the importance of easily accessible, printed medication information for better health outcomes.
Read MoreAn article was recently published in The Hill in which medical professionals stress the importance of clear and accurate health information for patients, especially in regards to prescription medications. The…
Read MoreThe President and Executive Director of the National Transitions of Care Coalition warned about medication non-adherence in aging and healthcare, advocating for standardized patient medication information.
Read MoreOn Wednesday AARP writer Katherine Skiba published an article outlining several challenges with online pharmacies and counterfeit drugs. She explained that the market for cheap Viagra, among other drugs, is…
Read MoreOver 30 years since the World Wide Web’s debut, internet, broadband, and smartphone use have increased for all Americans. However, disparities persist between lower and higher income groups. According to…
Read MorePPLA Comments on FDA Draft Guidance: Drug Abuse and Dependence Section of Labeling for Human Prescription Drug and Biological Products
Read MoreDear Commissioner Sharpless: On behalf of the Pharmaceutical Printed Literature Association (PPLA) I am pleased to submit thesecomments to the Food and Drug Administration (“FDA” or “Agency”) on the draft…
Read MoreThis week legalreader.com, a news source providing commentary on a variety of legal issues since 2002, published an article in which Dr. Sheldon H. Preskorn, MD, emphasized the importance of…
Read MoreYears-old Breach in Metro Boston Could Affect Thousands
Read MoreAtlanta’s City Government Has Been Hobbled by a Cyberattack and is Doing Some Business with Ink and Paper.
Read More